Kathleen F Kerr1, Eric R Morenz1, Heather Thiessen-Philbrook2, Steven G Coca3, F Perry Wilson4, Peter P Reese5, Chirag R Parikh6. 1. Department of Biostatistics, University of Washington, Seattle, Washington. 2. Division of Nephrology, School of Medicine, Johns Hopkins University, Baltimore, Maryland. 3. Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York. 4. Program of Applied Translational Research, Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut; and. 5. Renal-Electrolyte and Hypertension Division, Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 6. Division of Nephrology, School of Medicine, Johns Hopkins University, Baltimore, Maryland; Chirag.Parikh@jhmi.edu.
Abstract
BACKGROUND AND OBJECTIVES: In kidney transplantation, the relative contribution of donor versus other factors on clinical outcomes is unknown. We sought to quantify overall donor effects on transplant outcomes for kidney donations from deceased donors. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: For paired donations from deceased donors resulting in transplants to different recipients, the magnitude of donor effects can be quantified by examining the excess of concordant outcomes within kidney pairs beyond chance concordance. Using data from the Organ Procurement and Transplantation Network between the years 2013 and 2017, we examined concordance measures for delayed graft function, death-censored 1-year graft failure, and death-censored 3-year graft failure. The concordance measures were excess relative risk, excess absolute risk, and the fixation index (where zero is no concordance and one is perfect concordance). We further examined concordance in strata of kidneys with similar values of the Kidney Donor Profile Index, a common metric of organ quality. RESULTS: If the transplant of the kidney mate resulted in delayed graft function, risk for delayed graft function was 19% higher (95% confidence interval [95% CI], 18% to 20%), or 1.76-fold higher (95% CI, 1.73- to 1.80-fold), than baseline. If a kidney graft failed within 1 year, then the kidney mate's risk of failure was 6% higher (95% CI, 4% to 9%), or 2.85-fold higher (95% CI, 2.25- to 3.48-fold), than baseline. For 3-year graft failure, the excess absolute risk was 7% (95% CI, 4% to 10%) but excess relative risk was smaller, 1.91-fold (95% CI, 1.56- to 2.28-fold). Fixation indices were 0.25 for delayed graft function (95% CI, 0.24 to 0.27), 0.07 for 1-year graft failure (95% CI, 0.04 to 0.09), and 0.07 for 3-year graft failure (95% CI, 0.04 to 0.10). Results were similar in strata of kidneys with a similar Kidney Donor Profile Index. CONCLUSIONS: Overall results indicated that the donor constitution has small or moderate effect on post-transplant clinical outcomes.
BACKGROUND AND OBJECTIVES: In kidney transplantation, the relative contribution of donor versus other factors on clinical outcomes is unknown. We sought to quantify overall donor effects on transplant outcomes for kidney donations from deceased donors. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: For paired donations from deceased donors resulting in transplants to different recipients, the magnitude of donor effects can be quantified by examining the excess of concordant outcomes within kidney pairs beyond chance concordance. Using data from the Organ Procurement and Transplantation Network between the years 2013 and 2017, we examined concordance measures for delayed graft function, death-censored 1-year graft failure, and death-censored 3-year graft failure. The concordance measures were excess relative risk, excess absolute risk, and the fixation index (where zero is no concordance and one is perfect concordance). We further examined concordance in strata of kidneys with similar values of the Kidney Donor Profile Index, a common metric of organ quality. RESULTS: If the transplant of the kidney mate resulted in delayed graft function, risk for delayed graft function was 19% higher (95% confidence interval [95% CI], 18% to 20%), or 1.76-fold higher (95% CI, 1.73- to 1.80-fold), than baseline. If a kidney graft failed within 1 year, then the kidney mate's risk of failure was 6% higher (95% CI, 4% to 9%), or 2.85-fold higher (95% CI, 2.25- to 3.48-fold), than baseline. For 3-year graft failure, the excess absolute risk was 7% (95% CI, 4% to 10%) but excess relative risk was smaller, 1.91-fold (95% CI, 1.56- to 2.28-fold). Fixation indices were 0.25 for delayed graft function (95% CI, 0.24 to 0.27), 0.07 for 1-year graft failure (95% CI, 0.04 to 0.09), and 0.07 for 3-year graft failure (95% CI, 0.04 to 0.10). Results were similar in strata of kidneys with a similar Kidney Donor Profile Index. CONCLUSIONS: Overall results indicated that the donor constitution has small or moderate effect on post-transplant clinical outcomes.
Authors: Peter P Reese; Meera N Harhay; Peter L Abt; Matthew H Levine; Scott D Halpern Journal: J Am Soc Nephrol Date: 2015-09-14 Impact factor: 10.121
Authors: Sumit Mohan; Mariana C Chiles; Rachel E Patzer; Stephen O Pastan; S Ali Husain; Dustin J Carpenter; Geoffrey K Dube; R John Crew; Lloyd E Ratner; David J Cohen Journal: Kidney Int Date: 2018-05-05 Impact factor: 10.612
Authors: Wesley J Marrero; Abhijit S Naik; John J Friedewald; Yongcai Xu; David W Hutton; Mariel S Lavieri; Neehar D Parikh Journal: Transplantation Date: 2017-07 Impact factor: 4.939
Authors: Darren E Stewart; Victoria C Garcia; John D Rosendale; David K Klassen; Bob J Carrico Journal: Transplantation Date: 2017-03 Impact factor: 4.939
Authors: Kathleen F Kerr; Jeremy Roth; Kehao Zhu; Heather Thiessen-Philbrook; Allison Meisner; Francis Perry Wilson; Steven Coca; Chirag R Parikh Journal: Clin Trials Date: 2017-08-10 Impact factor: 2.486
Authors: Alexander F Schaapherder; Maria Kaisar; Lisa Mumford; Matthew Robb; Rachel Johnson; Michèle J C de Kok; Frederike J Bemelman; Jacqueline van de Wetering; Arjan D van Zuilen; Maarten H L Christiaans; Marije C Baas; Azam S Nurmohamed; Stefan P Berger; Esther Bastiaannet; Aiko P J de Vries; Edward Sharples; Rutger J Ploeg; Jan H N Lindeman Journal: EClinicalMedicine Date: 2022-06-25
Authors: Richard Dumbill; Roderick Jaques; Matthew Robb; Rachel Johnson; Rutger J Ploeg; Maria E Kaisar; Edward J Sharples Journal: J Clin Med Date: 2022-04-15 Impact factor: 4.964